No Data
No Data
Rundu Pharmaceutical Gets Regulatory Nod to Add Specification for Irbesartan Tablets
Zhuhai Rundu Pharmaceutical's (SZSE:002923) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Rundu Pharma Gets Active Pharmaceutical Ingredient Approval for Arthritis Drug
Zhuhai Rundu Pharmaceutical (002923.SZ): Hydroxychloroquine Sulfate has obtained the approval notice for the application for listing of chemical raw materials.
zhuhai rundu pharmaceutical (002923.SZ) announced that the company recently received the approval and issuance of hydroxy... by the National Medical Products Administration.
Rundu shares: report for the third quarter of 2024
Zhuhai Rundu Pharmaceutical (002923.SZ) released its performance for the first three quarters, with a net income of 37.1805 million yuan, a year-on-year decrease of 43.29%.
Zhuhai Rundu Pharmaceutical (002923.SZ) released the report for the first three quarters of 2024, during the reporting period the company achieved revenue...
No Data